Shares of Lyka Labs were locked at the upper circuit for the second straight day, up 5 per cent at Rs 129.15, also its 52-week high on the BSE on Tuesday, after Ipca Laboratories bought 1 million shares of pharmaceuticals company via open market deals.
On Monday, November 23, 2021, Ipca Laboratories purchased 1.05 million equity shares representing 3.65 per cent stake in Lyka Labs at price of Rs 123 per share on the BSE via bulk deals, the exchange data reveals.
Vipul Priyakant Dalal (240,121 shares) and Shreyans Jashwantlal Shah (345,000 shares) have sold the company’s shares
On Monday, November 23, 2021, Ipca Laboratories purchased 1.05 million equity shares representing 3.65 per cent stake in Lyka Labs at price of Rs 123 per share on the BSE via bulk deals, the exchange data reveals.
Vipul Priyakant Dalal (240,121 shares) and Shreyans Jashwantlal Shah (345,000 shares) have sold the company’s shares